Bioactive Peptides of Buffalo, Camel, Goat, Sheep, Mare, and Yak Milks and Milk Products

Food Reviews International

Volumn 29, Issue 1, 2013, Pages 1-23

  El Salam, M H Abd ^a   El Shibiny, S ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Bioactive peptides; Buffalo milk; Camel milk; Goat milk; Mare milk; Milk products; Milk protein hydrolyzates; Sheep milk; Yak milk

Indexed keywords

BIOACTIVE PEPTIDES; BUFFALO MILK; CAMEL MILKS; GOAT MILKS; MARE MILK; MILK PRODUCTS; MILK PROTEIN; SHEEP MILKS; YAK MILKS;

PEPTIDES;

DAIRY PRODUCTS;

BOS GRUNNIENS; CAPRA HIRCUS; MAMMALIA; OVIS ARIES;

EID: 84866667012     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559129.2012.692137     Document Type: Article

References (113)

1. Mellander, O. 1950. The physiological importance of the casein phosphopeptide calcium salt. II. Peroral calcium dosage of infants. Acta Soc. Med. Upsala, 55: 247-255.
2. Brantl, V., Teschemacher, H., Henschen, A. and Lottspeich, F. 1979. Novel opioid peptides derived from casein (β-casomorphin) I. Isolation from bovine casein peptone. Hoppe-Seyler Z. Physiol. Chem., 360: 1211-1216.
3. Korhonen, H. and Pihlanto, A. 2006. Bioactive peptides, production and functionality. Int. Dairy J., 16: 945-960.
4. Ricci, I., Artacho, R. and Olalla, M. 2010. Milk protein-peptides with angiotension I-converting enzyme (ACE) inhibitory activity. Crit. Rev. Food Sci. Nutr., 50: 390-402.
5. Kamou, S.M., Lu, R., Chen, W., Liu, X., Tian, F., Shen, Y. and Gao, T. 2010. Functional significance of bioactive peptides derived from milk proteins. Food Rev. Int. 26: 386-401.
6. Hartmann, R. and Meisel, H. 2007. Food-derived peptides with biological activity: From research to food applications. Curr. Opin. Biotechnol., 18: 163-169.
7. Hartmann, R. and Meisel, H. 2004. Caseinophosphopeptides and their cell modulating potential. Biofactors, 21: 73-78.
8. López-Expósito, I., Amigo, A.L. and Recio, I. 2007. Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides. Lait, 87: 241-249.
9. Kamou, S.M., Cheison, S.C., Chen, W., Liu, X.M. and Lu, R-R. 2010. Alpha-lactalbumin, its production technologies and bioactive peptides. Comp. Rev. Food Sci. Saf., 9: 197-212.
10. Tlipano, G., Sibilia, V., Cartoli, A.M. and Cocchi, D. 2011. Whey proteins as sources of dipeptidyldipeptidase IV (dipeptidyl peptidase 4) inhibitor. Peptides, 33: 835-838.
11. Cakir-Kiefer, C., Le Roux, Y., Balandras, F., Trabalon, M., Dary, A., Laurent, F., Gaillard, J.-L. and Miclo, L. 2011. In vitro digestibility of α-casozepine, a benzodiazepine-like peptide from bovine casein and biological activity of its main proteolytic fragment. J. Agric. Food Chem., 59: 4464-4472.
12. Tavares, T.G., Monterio, K.M., Possenti, A., Pintado, M.E., Carvalho, J.E. and Malcata, F.X. 2011. Antiulcerogenic activity of peptide concentrates obtained from hydrolysis of whey proteins by proteases from cynara cardunculus. Int. Dairy J., 21: 926-933.
13. Meisel, H. 2004. Multifunctional peptides encrypted in milk proteins. Biofactors. 21: 55-61.
14. Fitzgerald, R.J. and Murray, B.A. 2006. Bioactive peptides and lactic fermentations. Int. Dairy J., 59: 118-125.
15. Hemández-Leblsesma, B., Contreras, M.D. and Recio, I. 2011. Antihypertensive peptides, production, bioavailability and incorporation in foods. Adv. Colloid Interface Sci., 165: 23-35.
16. Tavares, T.G., Contreras, M.M., Amorim, M., Martin-Avarez, P.J., Pintado, M.E., Recio, I. and Malcata, F.X. 2011. Optimisation, by response surface methodology, of degree of hydrolysis and ACE-inhibitory activities of whey protein hydrolysates obtained with cardoon extract. Int. Dairy J., 21: 926-933.
17. Madureira, A.R., Pereira, C.I., Gomes, M.P., Pintado, M.E. and Malcata, F.X. 2007. Bovine whey proteins-Overview on the main biological properties. Food Res. Int., 40: 1197-1211.
18. Silva, S.V. and Malcata, F.X. 2005. Caseins as source of bioactive peptides. Int. Dairy J., 15: 1-15.
19. Madureira, A.R., Tavares, A.M.P, Gomes, M.P., Pintado, M.E. and Malcata, F.X. 2010. Physiological properties of bioactive peptides obtained from whey proteins. J. Dairy Sci., 93: 437-455.
20. Saguza-Carpos, M., Chel-Guenezo, L., Betancaz-Ancona, D. and Hornandez-Escelanta, V. 2011. Bioavailability of bioactive peptides. Food Rev. Int., 27: 213-226.
21. Faye, B. and Konuspayeva, G. 2011. The sustainability challenge to the dairy sector-The growing importance of non-cattle milk products worldwide. Keynote presentation, IDF International Symposium on Sheep's, Goat's and Other Non-Cow Milk, Athens, Greece, May: 16-18.
22. Al Haj, O.A. and Al Kanhal, H.A. 2010. Compositional, technological and nutritional aspects of dromedary camel milk. Int. Dairy J., 23: 811-821.
23. El-Agamy, E.I. 2009. "Bioactive components in camel milk". In Bioactive Components in Milk and Dairy Products, Edited by: Park, Y.W. 159-194. Ames, IA: Wiley-Blackwell.
24. D'Ambrosio, C., Arena, S., Salzano, A.M., Renzone, G., Ledda, L. and Scaloni, A. 2008. A proteomic characterization of water buffalo milk fractions describing PTM of major species and identification of minor fractions involved in nutrient delivery and defense against pathogens. Proteomic. 8: 3657-3666. and supporting information for Proteomic. doi:10/1002/pmic.200701148
25. De Simone, C., Ferranti, P., Picariello, G., Scognamiglia, I., Dicitore, A., Chianese, L., Addeo, F. and Stiuso, P. 2011. Peptides from water buffalo cheese whey induced senescence cell death via ceramide secretion in human colon adenocarcinoma cell line. Mol. Nutr. Food Res., 55: 229-238.
26. Lahav, E. and Regelson, E. 1996. Antibacterial and immunostimulating casein derived substances from milk: Casecidin and isracidin peptides. Food Chem. Toxicol., 31: 131-145.
27. Metwally, M.M., El-Shibiny, S., El-Dieb, S.M., El-Etriby, H.M. and Aseem, F.M. 2001. Large scale preparation and growth promoting effect on bifidobacteria of glycomacropeptide from sweet whey. Egypt J. Dairy Sci., 29: 37-52.
28. Petrilli, P., Pucci, P., Pelissier, J.P. and Addeo, F. 1987. Digestion by pancreatic juice of beta-casomorphin-containing fragment of buffalo beta-casein. Int. J. Pept. Protein Res., 29: 504-508.
29. Minervini, F., Algaron, F., Rizzello, C.G., Fox, P.F., Monnet, V. and Gobetti, M. 2003. Angiotension I-converting enzyme inhibitory and antibacterial peptides from. Lactobacillus helveticus PR4 proteinase hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol., 69: 5297-5305.
30. s2 casein and their antibacterial activity. Indian J. Dairy Sci., 58: 387-391.
31. De Simone, C., Picariello, G., Mamone, G., Stiuso, P., Dicitore, A., Vanacore, D., Chianese, L., Addeo, F. and Ferranti, P. 2009. Characterisation and cytomodulatory properties of peptides from mozzarella di bufala campana cheese whey. J. Pept. Sci., 15: 251-258.
32. Rizzello, C.G., Losito, I, Gobetti, M, Carbonara, T., De Bari, M.D. and Zambonin, P.G. 2005. Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties, J. Dairy Sci., 88: 2348-2360.
33. Food and Agriculture Organization. xxx. 2008 http://www.Fao.org/ag/againfo/themes/en/dairy/camel.hmtl (http://www.Fao.org/ag/againfo/themes/en/dairy/camel.hmtl)
34. Kappeler, S. 1998. "Compositional, structural analysis of camel milk proteins with emphasis on protective proteins". In D.T.S, Switzerland: dissertation, ETH, Zurich.
35. Farrell, H.M., Jr; Jimenez-Flores, R., Block, C.T., Brown, E.M., Buttler, J.E., Creamer, L.K., Hicks, C.L., Holler, C.M., Nig-Kwai-Hang, K.F. and Swaisgood, H.E. 2004. Nomenclature of the proteins of cow's milk-Six revision. J. Dairy Sci., 87: 1641-1674.
36. Salami, M., Yousefi, R., Ehsani, M.Z., Dalgalarrado, M., Chobert, J.-M., Haertle, T., Razavi, S.H., Saboury, A.A., Niasari-Nasiaji, A. and Moosavi-Movahadi, A.A. 2008. Kinetic characterization of hydrolysis of camel and bovine milk proteins by pancreatic enzymes. Int. Dairy J., 18: 1097-1102.
37. Shuangquan, Tsuda, H. and Miyamoto, T. 2008. Angiotension-I-converting enzyme inhibitory peptide in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China. J. Sci. Food Agric., 88: 2688-2692.
38. Salami, M., Moosavi-Movahadi, A.A., Ehsani, M.Z., Yousefi, R., Haertle, T., Chobert, J.-M., Razavi, S.H., Henerich, R., Saboury, A.A., Atri, H.S., Niasari-Nasiaji, A., Balalaie, S., Ebadi, S.A., Pourtakdoost, S. and Nasari-Nalaji, A. 2010. Improvement of the antimicrobial and antioxidant activities of camel and bovine whey proteins by limited proteolysis. J. Agric. Food Chem., 58: 3297-3303.
39. Beg, O.U., Bahr-Lindström, H. V., Zaidi, Z.H. and Jörnvall, H. 1985. The primary structure of α-lactalbumin from camel milk. Eur. J. Biochem., 147: 233-239.
40. Salami, M., Yousefi, R., Ehsani, M.Z., Razavi, S.H., Chobert, J.-M., Haertle, T., Saboury, A.A., Atri, H.S., Niasari-Nasiaji, A., Ahmed, F. and Moosavi-Movahadi, A.A. 2009. Enzymatic digestion and antioxidant activity of the native and molten globule states of camel α-lactalbumin: Possible significance for use in infant formula. Int. Dairy J., 19: 518-523.
41. Tavares, T.G., Contreras, M.M., Amorim, M., Martin-Avarez, P.J., Pintado, M.E., Recio, I. and Malcata, F.X. 2011. Novel whey-derived peptides with inhibitory effect against angiotension-converting enzyme: In vitro effect and stability to gastrointestinal enzymes. Peptides, 32: 1031-1039.
42. Azwai, S.M., Carter, S.D. and Woldehiwet, Z. 1999. Immunoglobulins of camel (Camelus dromedarius) colostrums. J. Comp. Pathol., 114: 273-282.
43. El-Hatmi, H., Girardet, J.-M., Gaillard, J.-L., Yahyaoui, M.H. and Attia, H. 2007. Characterization of whey proteins of (Camelus dromedarius) camel milk and colostrums. Small Rumin. Res., 70: 267-271.
44. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E.B., Bendhman, B. and Hamers, R. 1993. Naturally occurring antibodies devoid of light chains. Nature, 363: 446-448.
45. Lauwereys, M., Ghahroudi, M.A., Desmyter, A., Kime, J., Holzer, W., De Genst, E., Wyns, L. and Muyldermans, S. 1998. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J., 17: 3512-3520.
46. Girardet, J.-M., Saulnier, F., Gillard, J.-L., Ramet, J.-P. and Humbert, G. 2000. Camel (Camelus dromederius) milk PP3: Evidence of an insertion in the amino terminal sequence of the camel whey protein. Biochem. Cell Biol., 78: 19-26.
47. Kappeler, S., Farah, Z. and Puhan, Z. 1999. Alternative splitting of lactophorin mRNA from lactating mammary gland of the camel(Camelus dromedarius). J. Dairy Sci., 82: 2084-2093.
48. Sørensen, E.S. and Petersen, T.E. 1993. Phosphorylation, glycosylation and amino acid sequence of component PP3 from the proteose peptone fraction of bovine milk. J. Dairy Res., 60: 535-542.
49. Marletta, D., Crisciona, A., Bordanaro, S., Guastell, A.M. and D'Urso, G. 2007. Casein polymorphism in goat's milk. Lait, 86: 491-504.
50. Park, Y.W., Juarez, M., Ramos, M. and Haenlain, G.F.W. 2007. Physico-chemical characteristics of goat and sheep milk. Small Rumin. Res., 68: 88-113.
51. Yahyaoui, M.H., Angiolillo, A., Pilla, F., Sanchez, A. and Folch, J.M. 2003. Characterization and genotyping of the caprine κ-casein variants. J. Dairy Sci., 86: 2715-2720.
52. Manso, M.A. and López-Fandino, R. 2004. κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses. Food Rev. Int., 20: 329-355.
53. Moreno, F.J., Recio, I., Olano, A. and López-Fandino, R. 2001b. Heterogenity of caprine κ-casein macropeptide. J. Dairy Res., 67: 349-359.
54. Moreno, F.J., Olano, A. and Villamiel, M. 2001. N-acetyl and N-glycocyl neuraminic acid content in caprine κ-casein macropeptides. Milchwissenschaft, 56: 669-671.
55. Moatsou, G., Hatzinaki, A., Samolada, M. and Anifantakis, E. 2005. Major whey proteins in ovine and caprine acid wheys from indigenous Greek breeds. Int. Dairy J., 15: 123-131.
56. Lee, K.J., Kim, S.B., Ryu, J.S., Shin, H.S. and Lim, I.W. 2005. Separation and purification of angiotension converting enzyme inhibitory peptides from goat's milk casein hydrolysates. Asian-Aust. J. Anim. Sci., 18: 741-746.
57. Silva, S.V., Pihlanto, A. and Malcata, F.X. 2006. Bioactive peptides in ovine and caprine cheeselike system prepared with proteases from Cynara cardunculus. J. Dairy Sci., 89: 3336-3344.
58. Gómez-Ruiz, I.A., Ramos, M. and Recio, I. 2004. Angiotension-converting enzyme-inhibitory peptides in Manchego cheese. Stability under simulated gastrointestinal digestion. Int. Dairy J., 14: 1075-1080.
59. Manso, M.A. and López-Fandino, R. 2003. Angiotension I converting enzyme inhibitory activity of bovine, ovine and caprine kappa-casein macropeptide and their tryptic hydrolyzates. J. Food Protect., 66: 1686-1692.
60. Geerlings, A., Villar, I.C., Zarco, F.H., Sánchaz, M., Vera, R., Gomez, A.Z., Boza, J. and Duarte, J. 2006. Identification and characterization of novel angiotension converting enzyme inhibitors obtained from goat milk. J. Dairy Sci., 89: 3326-3335.
61. Manso, M.A., Escudero, C., Aligo, M. and López-Fandino, R. 2002. Platelet aggregation inhibitory activity of bovine, ovine and caprine κ-casein macropeptides and their tryptic hydrolyzates. J. Food Protect., 65: 1992-1996.
62. Hernández-Ledesma, B., Recio, I., Ramos, M. and Amigo, L. 2002. Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. Int. Dairy J., 12: 805-812.
63. Didelot, S., Bordenava-Juchereau, S., Rosenfeld, E., Fruitier-Araudier, I., Piot, J.-M. and Sannier, F. 2006. Preparation of angiotension I-converting enzyme inhibitory hydrolysates from unsupplemented caprine whey fermentation by various cheese microflora. Int. Dairy J., 16: 976-983.
64. Sieber, R., Bütikofer, U., Egger, C., Portmann, R., Walther, B. and Westler, D. 2010. ACE-inhibitory activity and ACE-inhibiting peptides in different cheese varieties. Dairy Sci. Technol., 90: 47-73.
65. Almaas, M., Berner, V., Holno, H., Langsrud, T. and Vegarud, G.E. 2008. Degradation of whey from caprine milk by human proteolytic enzymes and the resulting antibacterial effect against. Listeria monocytogenes. Small Rumin. Res., 79: 11-15.
66. Losito, I., Carbonara, T., De Bari, M.D., Gobbetti, M., Palmisano, F., Rizzello, C.G. and Zambonin, P.G. 2006. Identification of peptides in antimicrobial fractions of cheese extracts by electrospray ionization ion trap mass spectrometry coupled to a two-dimensional liquid chromatographic separation. Rapid Commun. Mass Spectrom. 20: 447-455.
67. Recio, I. and Visser, E. 2000. Antibacterial and binding characteristics of bovine, ovine and caprine lactoferrins: A comparative study. Int. Dairy J., 10: 597-605.
68. Vogel, H.J., Schibli, D.J., Jing, W., Lohmeier-Vogel, E.M., Epand, R.F. and Epand, R.M. 2002. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol., 80: 49-63.
69. Erikson, E.K., Vegarud, G.E., Langsrud, T., Almaas, H. and Lea, T. 2008. Effect of milk proteins and their hydrolysates on in vitro immune responses. Small Rumin. Res., 79: 29-37.
70. Shang, Q. and Fang, X. 2009. "Bioactive components in mare milk". In Bioactive Components in Milk and Dairy Products, Edited by: Park, Y.W. 195-216. Wiley-Blackwell: Ames, IA.
71. Lozovich, S. 1995. Medical uses of whole and fermented mare milk in Russia. Cult. Dairy Prod J., 30: 18-21.
72. Miranda, G., Mahé, M.-F., Leroux, C. and Martin, P. 2004. Proteomic tools to characterize the protein fraction of Equidae milk. Proteomics, 4: 2496-2509.
73. Uniacke-Lowe, T., Huppertz, T. and Fox, P.F. 2010. Equine milk proteins: Chemistry, structure and nutritional significance. Int. Dairy J., 20: 609-629.
74. Inglingstad, R.A., Devold, T.G., Eriksen, E.K., Holm, H., Jacobsan, M., Liland, K.H., Rukke, E.O. and Vegarnd, G.I. 2010. Comparison of the digestion of caseins and whey proteins in equine, bovine, caprine, camel and human milks by human gastrointestinal enzymes. Dairy Sci. Technol., 90: 549-563.
75. Miclo, L., Girardet, J.-M., Egito, A.S., Mollé, D., Martin, P. and Gaillard, J.-L. 2007. The primary structure of a low-Mr multiphosphorylated variant of β-casein in equine milk. Proteomics, 7: 1327-1335.
76. Girardet, J.-M., Miclo, L., Florent, S., Mollé, D. and Gaillard, J.-L. 2006. Determination of the phosphorylation level and deamidation susceptibility of equine β-casein. Proteomics, 6: 3707-3717.
77. Egito, A.S., Girardet, J.-M., Poirson, C., Mollé, D., Humbert, G.Miclo, L. 2003. Action of plasmin on equine β-casein. Int. Dairy J., 13: 813-820.
78. Egito, A.S., Girardet, J.-M., Miclo, L., Mollé, D., Humbert, G. and Gaillard, J.-L. 2001. Susceptibility of equine κ- and β-caseins to hydrolysis by chymosin. Int. Dairy J., 11: 885-893.
79. Chen, Y., Wang, Z., Chen, X., Liu, Y., Zhang, M. and Sun, T. 2010. Identification of angiotension-I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk. J. Dairy Sci., 93: 884-892.
80. Fujita, H., Yokoyama, K. and Yoshikawa, M. 2000. Classification and antihypertensive activity of angiotension-converting-enzyme inhibitory peptides derived from food proteins. J. Food Sci., 65: 564-569.
81. Recio, I., De la Fuente, M.A., Juárez, M. and Ramos, M. 2009. "Bioactive components in sheep milk". In Bioactive Components in Milk and Dairy Products, Edited by: Park, Y.W. 93-107. Wiley-Blackwell: Ames, IA.
82. Moatsou, G., Samolada, M., Katsabaki, A. and Anifantakis, E. 2004. Casein fractions of ovine milk from indigenous Greek breeds. Lait, 84: 285-296.
83. s1-casein. J. Agric. Food Chem., 46: 411-416.
84. s1-caseins: Localization of phosphoylation sites and characterization of genetic variants A, C and D. J. Dairy Res., 62: 281-296.
85. Amigo, L., Recio, I. and Ramos, M. 2000. Genetic polymorphism of ovine milk proteins: Its influence on technological properties of milk-A review. Int. Dairy J., 10: 135-149.
86. Glambra, I.J., Jěger, S. and Erhardt, G. 2010. Isoelectric focusing reveals additional casein variants in German sheep breeds. Small Rumin. Res., 90: 11-17.
87. s2-casein. Eur. J. Biochem., 201: 633-641.
88. s2-caseins. Small Rumin Res., 88: 84-88.
89. Ferranti, P., Garro, G., Laezza, P., Chianese, L. and Addeo, F. 1997. Identification of ovine heterogeneity by HPLC and electrospray mass spectrometry. Milk Protein Polymorphism,: 296-302. IDF special issue no. 9702. International Dairy Foundation: Brussels, Belgium
90. s1-casein variants and milk composition, micellar size and cheese yield". In Casein and Caseinates Structures, Interactions, Networks, Vol. Royaume-Uni: pp. 261, [21 May 1997], Scotland, UK: Hannah Symposium. [Hennah Research Institute]
91. El-Zahar, K., Sitohy, M., Choiset, Y., Metro, F., Haertle, T. and Clobert, J.M. 2005. Peptic hydrolysis of ovine β-lactoglobulin and α-lactalbumin. Exceptional susceptibility of native ovine β-lactoglobulin to pepsinolysis. Int. Dairy J., 15: 17-27.
92. Correa, A.P.E., Daroit, D.J., Coelho, J., Meira, S.M.M., Lopes, F.C., Segalin, J., Risso, P.H. and Brandelli, A.C. 2011. Antioxidant, antihypertensive and antimicrobial properties of ovine milk caseinate hydrolyzed with a microbial protease. J. Sci. Food Agric., 91: 2247-2254.
93. s2-casein. Int. Dairy J., 16: 1073-1080.
94. El-Zahar, K., Sitohy, M., Choiset, Y., Metro, F., Haertle, T. and Clobert, J.M. 2004. Antimicrobial activity of ovine whey proteins and their peptic hydrolysates. Milchwissenschaft, 59: 653-656.
95. Gómez-Ruiz, I.A., López-Expósito, I., Pihlanto, A., Ramos, M. and Recio, I. 2008. Antioxidant activity of ovine casein hydrolyzates, identification of active peptides by HPLC-MS/MS. Eur. Food Res. Technol., 227: 1061-1067.
96. Gómez-Ruiz, I.A., Ramos, M. and Recio, I. 2002. Angiotension-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. Int. Dairy J., 12: 697-726.
97. Gómez-Ruiz, I.A., Taborda, G., Amigo, L., Recio, I. and Ramos, M. 2006. Identification of ACE peptides in different Spanish cheese by Tandem mass spectroscopy. Eur. J. Food Res. Technol., 223: 595-601.
98. Gómez-Ruiz, J.A., Ramos, M. and Recio, I. 2007. Identification of novel angiotensin-converting-enzyme-inhibitory peptides from ovine milk proteins by CE-MS and chromatographic techniques. Electrophoresis, 28: 4202-4211.
99. Gómez-Ruiz, I.A., Ramos, M. and Recio, I. 2004. Angiotension-converting enzyme-inhibitory peptides in Manchego cheese. Stability under simulated gastrointestinal digestion. Int. Dairy J., 14: 1075-1080.
100. Chobert, J.-M., El-Zahar, K., Sitohy, M., Dalgalarrondo, M., Me{hook above}tro, F., Choisat, Y. and Haertle{hook above}, T. 2005. Angiotension I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine β-lactoglobulin and milk yoghurt obtained by using different starters. Lait, 85: 141-152.
101. Qian, Z. Y., Jollès, P., Migliore-Samour, D., Schoentgen, F. and Fiat, A. M. 1995. Sheep κ-casein peptides inhibit platelet aggregation. Biochim. Biophys. Acta, 1244: 411-417.
102. Papadimitiriou, C.G., Vafopouleu-Mastro, J., Annaki, A., Silva, S.V., Gomes, A.M., Malcata, F.X. and Alichanidis, E. 2007. Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotension-I-converting-enzyme (ACE)-inhibitory activity. Food Chem., 105: 647-656.
103. Recio, I., Quirós, A., Hernández-Ledesma, B., Gómez-Ruiz, I.A., Miguel, M., Amigo, L., López-Expósito, I., Ramos, M. and Aleixandre, A. Bioactive peptides identified in enzyme hydrolysates from milk caseins and procedure for their obtenation. U. S. Patent, PT/20100048464, February 25, 2010
104. Ochirkhuyog, B., Chobert, J.M., Dalgarrondo, M., Choiset, Y. and Hartle, T. 1997. Characterization of caseins from Mongolian yak and khainak and Bactrian camel. Lait, 77: 601-613.
105. Li, H., Ma, Y., Dong, A., Wang, J., Li, Q., Ha, S. and Maubois, J.-L. 2010. Protein composition of yak milk. Dairy Sci. Technol., 90: 111-117.
106. Mao, X.-Y., Ni, J.-R., Sun, W-L., Hao, P.-P. and Tan, L. 2007. Value added utilization of yak milk casein for the production of angiotension-I-converting enzyme inhibitory peptide. Food Chem., 103: 1282-1287.
107. Jiang, J., Chen, S., Ren, F., Luo, Z. and Zeng, S.S. 2007. Yak casein as a functional ingredient: Preparation and identification of angiotension-I-converting enzyme inhibitory peptides. J. Dairy Res., 74: 18-25.
108. Robert, M.C., Razaname, A., Mutter, M. and Juillerat, M.A. 2004. Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC2765. J. Agric. Food Chem., 52: 6923-6931.
109. Mao, X.-Y., Yang, H.Y., Song, J.P., Li, Y.H. and Ren, F.Z. 2007. Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro. J. Agric. Food Chem., 66: 638-642.
110. Mao, X.-Y., Ren, F. Z., Li, Y. H. and Nan, Q.X. 2006. Growth-inhibiting activity of yak casein and its hydrolysate to tumor cells. Milchwissenschaft, 61: 127-130.
111. Mao, X.-Y., Cheng, X., Wang, X. and Wu, S.-J. 2011. Free radical scavenging and anti inflammatory effect of yak milk casein before and after enzymatic hydrolysis. Food Chem., 126: 484-490.
112. Wang, X., Zhon, J., Jang, P. and Mao, X.-Y. 2011. Zinc-binding capacity of yak casein hydrolysates and zinc releasing characteristics of casein hydrolysate-zinc complexes. J. Dairy Sci., 94: 2731-274.
113. Wang, X, Li, M., Li, M., Mao, X., Zhou, J. and Ren, F. 2011. Preparation and characteristics of yak casein hydrolysate iron complex. Int. J. Food Sci. Technol., 46: 1705-1710.